Truvada
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Because of the severe health consequences of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and the…
Postexposure prophylaxis following sexual exposure (PEPSE) to HIV is increasingly being offered and accessed by patients. A…
Background Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV…
Background: Highly active antiretroviral therapy (HAART) has reduced the morbidity associated with HIV infection, and prolonged…
Twenty years after its original discovery, tenofovir has acquired a crucial position in the fight against human immunodeficiency…
The introduction of the highly active antiretroviral therapy (HAART) in 1996 has drastically reduced the morbidity and mortality…
ABSTRACT Daily preexposure prophylaxis (PrEP) with Truvada (emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF]) is a…
The objective was to evaluate the effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to Truvada® (TVD…
of results Of 139 patients, 81 were on Truvada and 58 on Kivexa. Most were black African (69%), mean age 38.1 (+/8.1) years and…